个人中心 - 老虎社区

困境反转and安全边际

IP属地：江苏

帖子 · 9帖子 · 9
关注 · 0关注 · 0
粉丝 · 0粉丝 · 0

- 困境反转and安全边际困境反转and安全边际
  ·2023-12-27
  这篇文章不错，转发给大家看看
  美股异动 | Cytokinetics盘前暴涨56%，心脏药物试验成功引发收购传闻
  https://www.zhitongcaijing.com/content/detail/1046286.html
  美股异动 | Cytokinetics盘前暴涨56%，心脏药物试验成功引发收购传闻
  1,010 评论
  点赞
  分享
  举报
- 困境反转and安全边际困境反转and安全边际
  ·2021-06-17
  已申购，希望万物新生（爱回收）股价大涨，给力点！！
  1,153 评论
  点赞
  分享
  举报
- 困境反转and安全边际困境反转and安全边际
  ·2021-05-04
  $美国钢铁(X)$杯柄形态。
  1,141 评论
  1
  分享
  举报
- 困境反转and安全边际困境反转and安全边际
  ·2021-01-05
  $小米集团-W(01810)$换机潮下最大的收益者
  1,129 评论
  点赞
  分享
  举报
- 困境反转and安全边际困境反转and安全边际
  ·2021-01-05
  $五菱汽车(00305)$这个股看不懂
  2,136 1
  点赞
  分享
  举报
- 困境反转and安全边际困境反转and安全边际
  ·2021-01-05
  $蓝月亮集团(06993)$冲着高瓴资本买的，好慌
  1,270 评论
  点赞
  分享
  举报
- 困境反转and安全边际困境反转and安全边际
  ·2020-11-30
  真是个小**
  @Mayday1203：
  $奥罗拉大麻公司(ACB)$隔壁都快50了，你争气点呀
  $奥罗拉大麻公司(ACB)$隔壁都快50了，你争气点呀
  1,130 评论
  点赞
  分享
  举报
- 困境反转and安全边际困境反转and安全边际
  ·2020-09-24
  非常不错的一本书，值得一读。
  1,606 1
  点赞
  分享
  举报
暂无粉丝

热议股票

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

老虎社区侵权投诉指引

中国互联网举报中心·北京互联网举报中心

网络谣言曝光台·扫黄打非举报中心

网络110报警服务

© 2018-2024 老虎社区版权所有

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

qrcode

关注我们

{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"3561522732812155","uuid":"3561522732812155","gmtCreate":1598431765753,"gmtModify":1678412360369,"name":"困境反转and安全边际","pinyin":"kjfzandaqbjkunjingfanzhuanandanquanbianji","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/0e36efbbc66958728ac528f8555fb21b","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":0,"headSize":55,"tweetSize":9,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":2,"name":"无畏虎","nameTw":"無畏虎","represent":"初生牛犊","factor":"发布3条非转发主帖,1条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-3","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"偶像虎友","description":"加入老虎社区1500天","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.10.05","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"228c86a078844d74991fff2b7ab2428d-3","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资合伙人虎","description":"证券账户累计交易金额达到100万美元","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":"93.63%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"传说交易员","description":"证券或期货账户累计交易次数达到300次","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":1,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"93.40%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"传说交易员","description":"证券或期货账户累计交易次数达到300次","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":1,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"93.78%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"江苏","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":256625297735800,"gmtCreate":1703686153314,"gmtModify":1703686154972,"author":{"id":"3561522732812155","authorId":"3561522732812155","name":"困境反转and安全边际","avatar":"https://static.tigerbbs.com/0e36efbbc66958728ac528f8555fb21b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3561522732812155","authorIdStr":"3561522732812155"},"themes":[],"htmlText":"这篇文章不错，转发给大家看看","listText":"这篇文章不错，转发给大家看看","text":"这篇文章不错，转发给大家看看","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/256625297735800","repostId":"1157890263","repostType":2,"repost":{"id":"1157890263","weMediaInfo":{"introduction":"港股挖掘机将每天为您推送最具价值的港股、美股、A股投资资讯！第一时间把握全球政策动向，先人一步了解主流资金流向，监测主力行踪，解读公司公告，追踪活跃个股，让您畅享投资财富盛宴!","home_visible":1,"media_name":"智通财经APP","id":"12","head_image":"https://static.tigerbbs.com/361f7f1ca0d64e919035653d64c723ab"},"pubTimestamp":1703685319,"share":"https://www.laohu8.com/m/news/1157890263?lang=&edition=full","pubTime":"2023-12-27 21:55","market":"us","language":"zh","title":"美股异动 | Cytokinetics盘前暴涨56%，心脏药物试验成功引发收购传闻","url":"https://stock-news.laohu8.com/highlight/detail?id=1157890263","media":"智通财经APP","summary":"https://www.zhitongcaijing.com/content/detail/1046286.html","content":"<html><head></head><body><p style=\"text-align: justify;\">12月27日，<a href=\"https://laohu8.com/S/CYTK\">Cytokinetics</a>表示，其正在研发的心脏病药物在一项受到密切关注的试验中帮助了患有遗传性心脏疾病的患者，这引发了有关该公司可能被收购的传言。消息公布后，该股盘前涨超56%。</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/14da3daddacf7f198a62a0c9bedec821\" title=\"\" tg-width=\"335\" tg-height=\"158\"/></p><p style=\"text-align: justify;\">Cytokinetics在一份声明中表示，与服用安慰剂的患者相比，该药物改善了患有心脏病的患者的运动能力和氧气摄取量。据此前报道称，在试验结果发布数月前，这家位于南旧金山的公司已经吸引了至少一家大型制药商的兴趣。</p><p style=\"text-align: justify;\">据了解，阿菲卡替尼(Aficamten)是一种口服治疗肥厚型心肌病(HCM)的药物，这是一种异常增厚的心肌干扰泵血的遗传疾病。</p><p style=\"text-align: justify;\">根据美国心脏协会的数据，每500人中就有多达1人患有此病，尽管许多人没有被诊断出来。这种疾病被认为是年轻人和竞技运动员突发心脏死亡的最常见原因。</p><p style=\"text-align: justify;\">此外，该公司的晚期试验招募了有症状的HCM患者，并观察了他们在运动能力、心力衰竭症状和整体功能上的改善。</p><p style=\"text-align: justify;\">如果获得美国监管机构的批准，这种药物将与去年获批用于治疗梗阻性HCM的<a href=\"https://laohu8.com/S/BMY\">施贵宝</a>的Camzyos竞争。在这种疾病中，最常见的是异常厚的肌肉阻塞了从心脏流向主动脉的血液。</p><p style=\"text-align: justify;\">值得一提的是，在Dealreporter报道称Cytokinetics正在接受<a href=\"https://laohu8.com/S/NVS\">诺华</a>制药和<a href=\"https://laohu8.com/S/AZN\">阿斯利康</a>的收购兴趣后，该公司股价上周飙升。如果发生收购，该交易将成为包括施贵宝在内的制药公司近期购买趋势的一部分。</p><p style=\"text-align: justify;\">据悉，施贵宝自去年10月以来至少已宣布了三次收购。这表明在制药行业中，大型公司通过收购其他公司或其资产来扩大自己的业务和产品线是一种常见的趋势，而施贵宝是这种趋势的一个典型例子。</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>美股异动 | Cytokinetics盘前暴涨56%，心脏药物试验成功引发收购传闻 </title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n美股异动 | Cytokinetics盘前暴涨56%，心脏药物试验成功引发收购传闻 \n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/12\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/361f7f1ca0d64e919035653d64c723ab);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">智通财经APP </p>\n<p class=\"h-time\">2023-12-27 21:55</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p style=\"text-align: justify;\">12月27日，<a href=\"https://laohu8.com/S/CYTK\">Cytokinetics</a>表示，其正在研发的心脏病药物在一项受到密切关注的试验中帮助了患有遗传性心脏疾病的患者，这引发了有关该公司可能被收购的传言。消息公布后，该股盘前涨超56%。</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/14da3daddacf7f198a62a0c9bedec821\" title=\"\" tg-width=\"335\" tg-height=\"158\"/></p><p style=\"text-align: justify;\">Cytokinetics在一份声明中表示，与服用安慰剂的患者相比，该药物改善了患有心脏病的患者的运动能力和氧气摄取量。据此前报道称，在试验结果发布数月前，这家位于南旧金山的公司已经吸引了至少一家大型制药商的兴趣。</p><p style=\"text-align: justify;\">据了解，阿菲卡替尼(Aficamten)是一种口服治疗肥厚型心肌病(HCM)的药物，这是一种异常增厚的心肌干扰泵血的遗传疾病。</p><p style=\"text-align: justify;\">根据美国心脏协会的数据，每500人中就有多达1人患有此病，尽管许多人没有被诊断出来。这种疾病被认为是年轻人和竞技运动员突发心脏死亡的最常见原因。</p><p style=\"text-align: justify;\">此外，该公司的晚期试验招募了有症状的HCM患者，并观察了他们在运动能力、心力衰竭症状和整体功能上的改善。</p><p style=\"text-align: justify;\">如果获得美国监管机构的批准，这种药物将与去年获批用于治疗梗阻性HCM的<a href=\"https://laohu8.com/S/BMY\">施贵宝</a>的Camzyos竞争。在这种疾病中，最常见的是异常厚的肌肉阻塞了从心脏流向主动脉的血液。</p><p style=\"text-align: justify;\">值得一提的是，在Dealreporter报道称Cytokinetics正在接受<a href=\"https://laohu8.com/S/NVS\">诺华</a>制药和<a href=\"https://laohu8.com/S/AZN\">阿斯利康</a>的收购兴趣后，该公司股价上周飙升。如果发生收购，该交易将成为包括施贵宝在内的制药公司近期购买趋势的一部分。</p><p style=\"text-align: justify;\">据悉，施贵宝自去年10月以来至少已宣布了三次收购。这表明在制药行业中，大型公司通过收购其他公司或其资产来扩大自己的业务和产品线是一种常见的趋势，而施贵宝是这种趋势的一个典型例子。</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/480431b5715196c0e96044cc36788e36","relate_stocks":{"BK4139":"生物科技","CYTK":"Cytokinetics","BK4505":"高瓴资本持仓"},"source_url":"","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1157890263","content_text":"12月27日，Cytokinetics表示，其正在研发的心脏病药物在一项受到密切关注的试验中帮助了患有遗传性心脏疾病的患者，这引发了有关该公司可能被收购的传言。消息公布后，该股盘前涨超56%。Cytokinetics在一份声明中表示，与服用安慰剂的患者相比，该药物改善了患有心脏病的患者的运动能力和氧气摄取量。据此前报道称，在试验结果发布数月前，这家位于南旧金山的公司已经吸引了至少一家大型制药商的兴趣。据了解，阿菲卡替尼(Aficamten)是一种口服治疗肥厚型心肌病(HCM)的药物，这是一种异常增厚的心肌干扰泵血的遗传疾病。根据美国心脏协会的数据，每500人中就有多达1人患有此病，尽管许多人没有被诊断出来。这种疾病被认为是年轻人和竞技运动员突发心脏死亡的最常见原因。此外，该公司的晚期试验招募了有症状的HCM患者，并观察了他们在运动能力、心力衰竭症状和整体功能上的改善。如果获得美国监管机构的批准，这种药物将与去年获批用于治疗梗阻性HCM的施贵宝的Camzyos竞争。在这种疾病中，最常见的是异常厚的肌肉阻塞了从心脏流向主动脉的血液。值得一提的是，在Dealreporter报道称Cytokinetics正在接受诺华制药和阿斯利康的收购兴趣后，该公司股价上周飙升。如果发生收购，该交易将成为包括施贵宝在内的制药公司近期购买趋势的一部分。据悉，施贵宝自去年10月以来至少已宣布了三次收购。这表明在制药行业中，大型公司通过收购其他公司或其资产来扩大自己的业务和产品线是一种常见的趋势，而施贵宝是这种趋势的一个典型例子。","news_type":1},"isVote":1,"tweetType":1,"viewCount":1010,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":163867434,"gmtCreate":1623871536428,"gmtModify":1623871536428,"author":{"id":"3561522732812155","authorId":"3561522732812155","name":"困境反转and安全边际","avatar":"https://static.tigerbbs.com/0e36efbbc66958728ac528f8555fb21b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3561522732812155","authorIdStr":"3561522732812155"},"themes":[],"htmlText":"已申购，希望万物新生（爱回收）股价大涨，给力点！！","listText":"已申购，希望万物新生（爱回收）股价大涨，给力点！！","text":"已申购，希望万物新生（爱回收）股价大涨，给力点！！","images":[{"img":"https://static.tigerbbs.com/43d94aa12613ce2e29327370f0eb6ae7","width":"1080","height":"2340"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/163867434","isVote":1,"tweetType":1,"viewCount":1153,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":106928595,"gmtCreate":1620085278817,"gmtModify":1620085278817,"author":{"id":"3561522732812155","authorId":"3561522732812155","name":"困境反转and安全边际","avatar":"https://static.tigerbbs.com/0e36efbbc66958728ac528f8555fb21b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3561522732812155","authorIdStr":"3561522732812155"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/X\">$美国钢铁(X)$</a>杯柄形态。","listText":"<a href=\"https://laohu8.com/S/X\">$美国钢铁(X)$</a>杯柄形态。","text":"$美国钢铁(X)$杯柄形态。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/106928595","isVote":1,"tweetType":1,"viewCount":1141,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":338940340,"gmtCreate":1609815761480,"gmtModify":1703740641658,"author":{"id":"3561522732812155","authorId":"3561522732812155","name":"困境反转and安全边际","avatar":"https://static.tigerbbs.com/0e36efbbc66958728ac528f8555fb21b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3561522732812155","authorIdStr":"3561522732812155"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/01810\">$小米集团-W(01810)$</a>换机潮下最大的收益者","listText":"<a href=\"https://laohu8.com/S/01810\">$小米集团-W(01810)$</a>换机潮下最大的收益者","text":"$小米集团-W(01810)$换机潮下最大的收益者","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/338940340","isVote":1,"tweetType":1,"viewCount":1129,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":338957139,"gmtCreate":1609815630321,"gmtModify":1703740640630,"author":{"id":"3561522732812155","authorId":"3561522732812155","name":"困境反转and安全边际","avatar":"https://static.tigerbbs.com/0e36efbbc66958728ac528f8555fb21b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3561522732812155","authorIdStr":"3561522732812155"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/00305\">$五菱汽车(00305)$</a>这个股看不懂","listText":"<a href=\"https://laohu8.com/S/00305\">$五菱汽车(00305)$</a>这个股看不懂","text":"$五菱汽车(00305)$这个股看不懂","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/338957139","isVote":1,"tweetType":1,"viewCount":2136,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":338957930,"gmtCreate":1609815610620,"gmtModify":1703740640287,"author":{"id":"3561522732812155","authorId":"3561522732812155","name":"困境反转and安全边际","avatar":"https://static.tigerbbs.com/0e36efbbc66958728ac528f8555fb21b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3561522732812155","authorIdStr":"3561522732812155"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/06993\">$蓝月亮集团(06993)$</a>冲着高瓴资本买的，好慌","listText":"<a href=\"https://laohu8.com/S/06993\">$蓝月亮集团(06993)$</a>冲着高瓴资本买的，好慌","text":"$蓝月亮集团(06993)$冲着高瓴资本买的，好慌","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/338957930","isVote":1,"tweetType":1,"viewCount":1270,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":391413839,"gmtCreate":1606747193721,"gmtModify":1703844155641,"author":{"id":"3561522732812155","authorId":"3561522732812155","name":"困境反转and安全边际","avatar":"https://static.tigerbbs.com/0e36efbbc66958728ac528f8555fb21b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3561522732812155","authorIdStr":"3561522732812155"},"themes":[],"htmlText":"真是个小**","listText":"真是个小**","text":"真是个小**","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/391413839","repostId":"391413077","repostType":1,"repost":{"id":391413077,"gmtCreate":1606747167399,"gmtModify":1703844154948,"author":{"id":"3560750769077829","authorId":"3560750769077829","name":"Mayday1203","avatar":"https://static.tigerbbs.com/967c46fbcb8b4d522e18d6f1bbcede1c","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560750769077829","authorIdStr":"3560750769077829"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ACB\">$奥罗拉大麻公司(ACB)$</a>隔壁都快50了，你争气点呀","listText":"<a href=\"https://laohu8.com/S/ACB\">$奥罗拉大麻公司(ACB)$</a>隔壁都快50了，你争气点呀","text":"$奥罗拉大麻公司(ACB)$隔壁都快50了，你争气点呀","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/391413077","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":1130,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":974913391,"gmtCreate":1600888380613,"gmtModify":1703822889439,"author":{"id":"3561522732812155","authorId":"3561522732812155","name":"困境反转and安全边际","avatar":"https://static.tigerbbs.com/0e36efbbc66958728ac528f8555fb21b","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3561522732812155","authorIdStr":"3561522732812155"},"themes":[],"htmlText":"非常不错的一本书，值得一读。","listText":"非常不错的一本书，值得一读。","text":"非常不错的一本书，值得一读。","images":[{"img":"https://static.tigerbbs.com/a095839b3325eaa6b8069c17f3734c9e","width":"600","height":"600"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/974913391","isVote":1,"tweetType":1,"viewCount":1606,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3527667803686145","authorId":"3527667803686145","name":"社区成长助手","avatar":"https://static.tigerbbs.com/2b7c7106b5c0c8b0037faa67439d898f","crmLevel":1,"crmLevelSwitch":0,"idStr":"3527667803686145","authorIdStr":"3527667803686145"},"content":"终于等到了您的初发帖[比心][比心]发帖时关联相关股票或者相关话题，可以获得更多曝光哦～如果您想创作优质文章，请查看老虎社区创作指引","text":"终于等到了您的初发帖[比心][比心]发帖时关联相关股票或者相关话题，可以获得更多曝光哦～如果您想创作优质文章，请查看老虎社区创作指引","html":"终于等到了您的初发帖[比心][比心]发帖时关联相关股票或者相关话题，可以获得更多曝光哦～如果您想创作优质文章，请查看老虎社区创作指引"}],"imageCount":1,"langContent":"CN","totalScore":0}],"defaultTab":"followers","isTTM":false}